Back
Revance Therapeutics Stock Predictions
Sponsored
RVNC
Sponsored
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
21
RVNC
Revance Therapeutics
Last Price:
5.86
Seasonality Move:
-5.59%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock marketRevance Therapeutics Stock Forecast
- Over the next 52 weeks, Revance Therapeutics has on average historically risen by 5.2% based on the past 10 years of stock performance.
- Revance Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Revance Therapeutics Stock Undervalued?
The current Revance Therapeutics [RVNC] share price is $5.99. The Score for RVNC is 21, which is 58% below its historic median score of 50, and infers higher risk than normal. - RVNC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Revance Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Revance Therapeutics has on average historically risen by 5.2% based on the past 10 years of stock performance.
Revance Therapeutics Stock Rating
Sell
21
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics overpriced?
- Revance Therapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Revance Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
revance.com
52-Week Data
52-Week High:
14.24
52-Week Low:
2.30
Prediction Charts
Market Cap:
624.04M
Price in USD:
5.99
Volume:
5.5M
Beta:
1.03
Technical Analysis
SMA50:
5.16
SMA100:
4.11
SMA200:
5.05
52-Wk Change:
-64.13%
Stock Predictions
-
Is Revance Therapeutics stock public?
Yes, Revance Therapeutics is a publicly traded company. -
What is the Revance Therapeutics stock quote today?
The Revance Therapeutics stock price is 5.99 USD today. -
How to buy Revance Therapeutics stock online?
You can buy Revance Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 6.59 | 6.57 | 6.59 | 6.55 |
Aug-30 | 6.57 | 6.57 | 6.59 | 6.57 |
Sep-3 | 6.57 | 6.59 | 6.59 | 6.57 |
Sep-4 | 6.58 | 6.58 | 6.59 | 6.57 |
Sep-5 | 6.58 | 6.57 | 6.58 | 6.55 |
Sep-6 | 6.56 | 6.57 | 6.58 | 6.54 |
Sep-9 | 6.58 | 6.59 | 6.59 | 6.57 |
Sep-10 | 6.57 | 6.57 | 6.58 | 6.55 |
Sep-11 | 6.57 | 6.58 | 6.59 | 6.56 |
Sep-12 | 6.58 | 6.56 | 6.59 | 6.54 |
Sep-13 | 6.58 | 6.55 | 6.59 | 6.54 |
Sep-16 | 6.54 | 5.97 | 6.57 | 5.44 |
Sep-17 | 6.02 | 5.97 | 6.27 | 5.85 |
Sep-18 | 5.95 | 5.99 | 6.30 | 5.90 |
Revance Therapeutics Earnings
Revance Therapeutics Earnings Report: Per Share Revance Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Revance Therapeutics Forecast Revenue Growth
Revance Therapeutics Stock Analysis: Historical quarterly revenues per share for Revance Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.40 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.
* Revance Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.